This summit is a CME/ACPE‑accredited event that unites leading experts in hematologic malignancies to deliver updates on emerging strategies and advances in the treatment of multiple myeloma and lymphoma. Sessions include:
- Pivotal clinical trial data and updated practice guidelines
- Case-based discussions featuring immunotherapies such as CAR‑T cells and T‑cell redirecting bispecific antibodies
- Practical management strategies for treatment-related toxicities and personalized patient care
Target audiences include medical oncologists, hematology fellows, oncology nurses, nurse practitioners, physician assistants, and pharmacists.